Headline News Archive
Click on title to read the full article.
Genentech asks for Avastin hearing
December 28, 2020
By San Francisco Business Times
Genentech Inc. filed a formal request Thursday with the Food and Drug Administration for a hearing on the agency's plan to rescind approval of the world’s best-selling cancer drug, Avastin, for women with metastatic breast cancer.
Denosumab superior to zoledronic acid in delaying first skeletal-related side effect in breast cancer patients
December 23, 2020
By Ken Krizner
A newly approved drug, denosumab (Xgeva, Amgen), delays skeletal-related side effects for 5 months longer compared to zoledronic acid (Zometa and Reclast, Novartis) in patients with breast cancer and bone metastases, according to phase 3 trial results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
U.S., Europe differ on Avastin as a breast cancer treatment, creating confusion
December 20, 2020
By CARLY WEEKS, Globe and Mail Update
Contradictory decisions made in the United States and Europe last week about a drug used to treat breast cancer are creating controversy and confusion over whether patients should still have access to it.
FDA begins process to remove breast cancer indication from Avastin label
December 16, 2020
By FDA NEWS RELEASE
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use. The agency is making this recommendation after reviewing the results of four clinical studies of Avastin in women with breast cancer and determining that the data indicate that the drug does not prolong overall survival in breast cancer patients or provide a sufficient benefit in slowing disease progression to outweigh the significant risk to patients.
SABCS: Delay Chemo to Aid Wound Healing
December 14, 2020
By Ed Susman, Contributing Writer, MedPage Today
SAN ANTONIO -- Therapy for metastatic breast cancer that includes bevacizumab (Avastin) should be delayed at least seven days after venous access lines are implanted to prevent wound complications and promote healing, French researchers suggested here
Bevacizumab-Containing Therapy Beneficial for Triple-Negative Metastatic Breast Cancer in Real-World Practice: Presented at SABC
December 14, 2020
By Ed Susman, Contributing Writer, MedPage Today
SAN ANTONIO, Tex -- December 14, 2020 -- Real-world clinical practice use of bevacizumab in combination with taxanes appears to provide similar benefits to those observed in randomised, controlled clinical trials, according to a study presented here at the 33rd annual San Antonio Breast Cancer Symposium (SABCS). In a general practice setting -- the basis for the ATHENA trial -- researchers observed a median overall survival of 25.2 months among the 2,264 patients included in the study who were treated with bevacizumab and mainly taxane-containing regimens.
Ibandronate Beneficial For Patients with Breast Cancer and Bone Metastases in Many Ways
December 13, 2020
By Ria Patel
As per a recent study, Ibandronate could prove as an effective treatment for relieving pain and is also safe to use by patients with breast cancer with metastatic bone disease (MBD).
Circulating Tumor Cells: Useful Tool in Metastatic Breast Cancer?
December 13, 2020
By Zosia Chustecka
December 11, 2020 (San Antonio, Texas) — Measuring circulating tumor cells (CTCs) is a useful tool for managing patients with metastatic breast cancer, says one breast cancer expert, but another disagrees and says it adds nothing to the information that is already available clinically and from imaging.
Elizabeth Edwards inspired her fellow Stage IV sisters
December 12, 2020
By Chicago Tribune, Voice of the People, Katherine O'Brien
She inspired her fellow Stage IV sisters.
Despite her illness she maintained an active schedule - a source of hope for those similarly afflicted.We hear often about women, particularly celebrities, who have completed their treatment for an early-stage breast cancer. We rarely hear about women like Edwards whose breast cancer is treatable but ultimately unbeatable.
A hero of hope on cancer
December 10, 2020
By Rev. Pamela J. Breakey
The Metastatic Breast Cancer Network grieves with and for the Edwards family and the nation over the death of Elizabeth Edwards.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007